Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10018882
Fusion event
HBV-EOGT integration
Validated
No
Detection method
VirusFinder
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2017
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
Start
1825
Integrated sequence
TAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTT| |TTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGGGCATGGACATCGACCCTTATAAAGA
Host Sequence
Chromosome
chr3
Cytoband
p14.1
Reference genome
Start
End
69030253/68981102 (Hg38)
Location type
Intron3
Target gene
miRNAs that regulate target gene
hsa-mir-155-5p ; hsa-mir-9-5p ; hsa-mir-132-3p ; hsa-mir-124-3p ; hsa-mir-192-5p ; hsa-mir-30e-3p ; hsa-mir-30d-3p ; hsa-mir-30a-3p ; hsa-mir-599 ; hsa-mir-548aw ; hsa-mir-4276 ; hsa-mir-3161 ; hsa-mir-137 ; hsa-mir-4766-3p ; hsa-mir-1468-3p ; hsa-mir-548x-5p ; hsa-mir-548g-5p ; hsa-mir-548f-5p ; hsa-mir-548aj-5p ; hsa-mir-642b-3p ; hsa-mir-642a-3p ; hsa-mir-3908 ; hsa-mir-425-5p ; hsa-mir-4703-5p ; hsa-mir-3942-5p ; hsa-mir-944 ; hsa-mir-3121-3p ; hsa-mir-152-3p ; hsa-mir-148b-3p ; hsa-mir-148a-3p ; hsa-mir-3666 ; hsa-mir-454-3p ; hsa-mir-301a-3p ; hsa-mir-130b-3p ; hsa-mir-130a-3p ; hsa-mir-4295 ; hsa-mir-301b-3p ; hsa-mir-19b-3p ; hsa-mir-19a-3p ; hsa-mir-5007-3p ; hsa-mir-4261 ; hsa-mir-205-3p ; hsa-mir-3688-3p ; hsa-mir-5011-5p ; hsa-mir-410-3p ; hsa-mir-6512-5p ; hsa-mir-4694-3p ; hsa-mir-19a-5p ; hsa-mir-19b-1-5p ; hsa-mir-19b-2-5p ; hsa-mir-2052 ; hsa-mir-223-5p ; hsa-mir-297 ; hsa-mir-3680-3p ; hsa-mir-4307 ; hsa-mir-450b-5p ; hsa-mir-4520-5p ; hsa-mir-4666b ; hsa-mir-5011-3p ; hsa-mir-507 ; hsa-mir-557 ; hsa-mir-567 ; hsa-mir-574-5p ; hsa-mir-6867-5p
Nearest miRNA
hsa-let-7g/Upstream/1755575; hsa-mir-12124/Downstream/67856;
Nearest CpG islands
None/Target, chr3-CpG: 148/Upstream/48218, chr3-CpG: 119/Downstream/31906
Upstream sequence
CTACCTACCCGCCCCACCCAGGGGGCAACGCGAGAGTCGCTAAGCGGCTGCGTACTCCCGACGGCGTAACTGACAGGAGCTTTACTCCAACCAGAATACG
Downstream sequence
tctgtaaaatgggactagctgggccaactcagaagactgttgaaagcgtgagatgagataaagcaagtaaGCATAAAAGTACATTTCGATAAATAGTAGC
Reference
Yoo, S., et al. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis. BMC Med ,2017, 15(1): 214.